Casdin Capital, LLC Q2 2025 Filing

Filed August 14, 2025

Portfolio Value

$1.1T

Holdings

33

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (33 positions)

#StockSharesValue% PortfolioType
1
WGSGENEDX HOLDINGS CORP
3,507,164$323.7B29.48%
2
BLFSBIOLIFE SOLUTIONS INC
7,707,165$166.0B15.12%
3
RVMDREVOLUTION MEDICINES INC
2,887,933$106.2B9.68%
4
FLBSTANDARD BIOTOOLS INC
76,075,636$91.3B8.31%
5
ILMNILLUMINA INC
645,000$61.5B5.60%
6
RNAAVIDITY BIOSCIENCES INC
1,775,000$50.4B4.59%
7
VERVVERVE THERAPEUTICS INC
4,095,571$46.0B4.19%
8
RLAYRELAY THERAPEUTICS INC
11,398,574$39.4B3.59%
9
ALNYALNYLAM PHARMACEUTICALS INC
81,500$26.6B2.42%
10
GPCRSTRUCTURE THERAPEUTICS INC
1,225,000$25.4B2.31%
11
BEAMBEAM THERAPEUTICS INC
1,450,000$24.7B2.25%
12
NGNENEUROGENE INC
1,295,361$19.4B1.76%
13
CDXSCODEXIS INC
7,200,000$17.6B1.60%
14
SRPTSAREPTA THERAPEUTICS INC
990,097$16.9B1.54%
15
DNLIDENALI THERAPEUTICS INC
890,000$12.5B1.13%
16
HIMSHIMS & HERS HEALTH INC
230,000$11.5B1.04%
17
MAZEMAZE THERAPEUTICS INC
758,857$9.3B0.85%
18
VCYTVERACYTE INC
276,308$7.5B0.68%
19
LLYELI LILLY & CO
8,500$6.6B0.60%
20
SNDXSYNDAX PHARMACEUTICALS INC
650,000$6.1B0.55%
21
SEPNSEPTERNA INC
553,268$5.8B0.53%
22
GHGUARDANT HEALTH INC
100,000$5.2B0.47%
23
EXASEXACT SCIENCES CORP
90,000$4.8B0.44%
24
PRMEPRIME MEDICINE INC
1,567,175$3.9B0.35%
25
AGIOAGIOS PHARMACEUTICALS INC
100,000$3.3B0.30%
26
ABSIABSCI CORPORATION
973,260$2.5B0.23%
27
PACBPACIFIC BIOSCIENCES CALIF IN
723,767$897.5M0.08%
28
RXRXRECURSION PHARMACEUTICALS IN
165,323$836.5M0.08%
29
IPSCCENTURY THERAPEUTICS INC
1,228,190$686.2M0.06%
30
CTNMCONTINEUM THERAPEUTICS INC
148,333$588.9M0.05%
31
DNAGINKGO BIOWORKS HOLDINGS INC
36,493$410.5M0.04%
32
GLUEMONTE ROSA THERAPEUTICS INC
86,014$387.9M0.04%
33
TNYATENAYA THERAPEUTICS INC
361,969$221.2M0.02%